Literature DB >> 18839197

Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Elisabeth Victoria Sjögren1, Ruud G J Wiggenraad, Saskia Le Cessie, Simone Snijder, Jaqueline Pomp, Robert Jan Baatenburg de Jong.   

Abstract

We evaluated the radiation outcome and prognostic factors in a population-based study of early (T1N0M0) glottic carcinoma. Survival parameters and prognostic factors were evaluated by uni- and multivariate analysis in 316 consecutive irradiated patients with T1 glottic carcinoma in the Comprehensive Cancer Center West region of the western Netherlands. Median follow-up was 70 months (range 1-190 months). Five and ten-year local control was 86 and 84%. Disease specific survival was 97% at 5 and 10 years. In multivariate analysis, pre-existent laryngeal hypertrophic laryngitis was the only predictive factor for local control (relative risk = 3.0, P = 0.02). Comorbidity was prognostic for overall survival. No factor was predictive for disease specific survival. Pre-existent laryngeal hypertrophic laryngitis is a new risk factor associated with reduced local control in T1 glottic carcinoma treated with radiotherapy.

Entities:  

Mesh：

Year:  2008        PMID： 18839197     DOI： 10.1007/s00405-008-0803-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  42 in total

1.  Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.

Authors:  D J Canaday; W F Regine; M Mohiuddin; W Zollinger; M Machtay; J Lee; D Schultz; M S Rudoltz
Journal:  Radiat Oncol Investig       Date:  1999

2.  Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

Authors:  Patti A Groome; Brian O'Sullivan; William J Mackillop; Lynda D Jackson; Karleen Schulze; Jonathan C Irish; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

3.  Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome.

Authors:  H E Eckel
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-01       Impact factor: 1.547

Review 4.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy.

Authors:  W M Mendenhall; R J Amdur; C G Morris; R W Hinerman
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

6.  Clinical radiobiology of glottic T1 squamous cell carcinoma.

Authors:  K Skladowski; R Tarnawski; B Maciejewski; A Wygoda; K Slosarek
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

7.  Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.

Authors:  Jing Jin; Zhongxing Liao; Li Gao; Xiaodong Huang; Guozhen Xu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

8.  Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy.

Authors:  Elisabeth V Sjögren; Maya A van Rossum; Ton P M Langeveld; Marika S Voerman; Vivienne A H van de Kamp; Mark O W Friebel; Ron Wolterbeek; Robert J Baatenburg de Jong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-09

9.  Treatment of early carcinoma of the vocal cords by radiotherapy.

Authors:  G Stevens; G Castle; C J O'Brien
Journal:  Australas Radiol       Date:  1994-05

10.  Radiotherapy. The mainstay in the treatment of early glottic carcinoma.

Authors:  P K Pellitteri; T L Kennedy; D P Vrabec; D Beiler; M Hellstrom
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-03
View more
  14 in total

Review 1.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

2.  Adverse histopathological findings in glottic cancer with anterior commissure involvement.

Authors:  Małgorzata Leszczyńska; Maciej Tokarski; Donata Jarmołowska-Jurczyszyn; Paweł Kosikowski; Witold Szyfter; Małgorzata Wierzbicka
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-21       Impact factor: 2.503

3.  Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.

Authors:  Nicola Dinapoli; Claudio Parrilla; Jacopo Galli; Rosa Autorino; Francesco Miccichè; Francesco Bussu; Mario Balducci; Lucia D'Alatri; Raffaella Marchese; Mario Rigante; Giuseppe Di Lella; Luca Liberati; Giovanni Almadori; Gaetano Paludetti; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

Review 4.  Salivary gland cancer stem cells.

Authors:  April Adams; Kristy Warner; Jacques E Nör
Journal:  Oral Oncol       Date:  2013-06-28       Impact factor: 5.337

5.  Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.

Authors:  A J Remmelts; F J P Hoebers; W M C Klop; A J M Balm; O Hamming-Vrieze; M W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

Review 6.  Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives.

Authors:  Benoîte Méry; Jean-Baptiste Guy; Sophie Espenel; Anne-Sophie Wozny; Stéphanie Simonet; Alexis Vallard; Gersende Alphonse; Dominique Ardail; Claire Rodriguez-Lafrasse; Nicolas Magné
Journal:  World J Stem Cells       Date:  2016-01-26       Impact factor: 5.326

7.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

8.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

9.  Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma.

Authors:  Christine D L van Gogh; Irma M Verdonck-de Leeuw; Jeanne Wedler-Peeters; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

10.  Cancer stem cells in head and neck cancer.

Authors:  Eugenia Allegra; Serena Trapasso
Journal:  Onco Targets Ther       Date:  2012-11-21       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.